Skip to content
Pediatric Ophthalmology & Strabismus

Oculocutaneous Albinism (Ocular Albinism)

1. What is Oculocutaneous Albinism (Ocular Albinism)?

Section titled “1. What is Oculocutaneous Albinism (Ocular Albinism)?”

Oculocutaneous albinism (OCA) and ocular albinism (OA) are a group of hereditary disorders characterized by congenital deficiency of melanin production, leading to hypopigmentation of the skin, hair, and eyes.

The two main types are (1) OCA, which presents with widespread hypopigmentation of the skin, hair, and eyes (autosomal recessive inheritance), and (2) OA, in which symptoms are limited to the eyes (X-linked recessive inheritance).

OCA is further classified into several types based on the causative gene. The most common is OCA2 (OCA2 gene mutation), and the most severe is OCA1 (TYR gene mutation). OA1 manifests in male patients; carrier mothers usually lack ocular symptoms, but characteristic mosaic findings in the fundus provide diagnostic clues.

Syndromic albinism includes Chédiak-Higashi syndrome (associated with immunodeficiency) and Hermansky-Pudlak syndrome (associated with bleeding tendency), requiring attention to systemic complications.

TypeCausative geneInheritance patternMain features
OCA1aTYR (tyrosinase activity zero)ARMost severe. Skin, hair, and eyes completely lack pigment.
OCA1bTYR (reduced tyrosinase activity)ARSmall amounts of melanin are produced with age
OCA2OCA2ARMost common. More frequent in African descent
OCA3TYRP1ARCommon in African descent. Reddish skin tone
OCA4SLC45A2ARRelatively common in East Asian descent
OA1GPR143XLROcular symptoms only. Affects males. Mosaic findings in mother’s fundus.

Common ocular abnormalities across all types include nystagmus, photophobia, reduced visual acuity, foveal hypoplasia, and increased iris transillumination. In OCA, depigmentation of the fundus is prominent, and iris transillumination is markedly increased. In OA, retinal depigmentation is relatively mild.

  • Nystagmus: Pendular or rapid nystagmus appears from infancy
  • Photophobia: Severe glare due to increased light scattering
  • Reduced visual acuity: Depends on the degree of foveal hypoplasia; corrected visual acuity ranges from 0.1 to 0.5, with large individual differences

An albinotic fundus is characteristic. Due to melanin deficiency in the retinal pigment epithelium, the choroidal vessels become more visible, and the entire fundus appears orange-red. In OCA, depigmentation is severe, while in OA it is relatively mild.

Foveal hypoplasia: Melanin or RPE signals are required for embryonic foveal differentiation; when deficient, foveal differentiation and formation are incomplete. OCT shows absence of the foveal pit, and fluorescein angiography shows loss or reduction of the foveal avascular zone (FAZ).

In OCA, the iris also lacks pigment, so light can be seen through it like a pupil when illuminated from the side (increased iris transillumination). In OA, changes in iris transillumination are mild.

In OA1, the ERG is generally normal. In types with high myopia, ERG findings resembling incomplete stationary night blindness may be present.

In carriers of OA1 (mothers), a mosaic fundus with patchy depigmentation and pigmentation may be observed in the peripheral retina. This is an important finding that aids in carrier diagnosis of the mother.

Abnormalities in the Melanin Synthesis Pathway

Section titled “Abnormalities in the Melanin Synthesis Pathway”

The melanin synthesis pathway is tyrosine → DOPA → dopaquinone → melanin, with tyrosinase (TYR) acting as the rate-limiting enzyme.

  • OCA1: Deficiency or reduction in TYR (tyrosinase) activity → complete or partial loss of melanin production
  • OCA2: Dysfunction of OCA2 protein (regulation of melanosome pH) → reduced melanin synthesis
  • OCA3: Abnormality of TYRP1 (tyrosinase-related protein 1)
  • OCA4: Abnormality of SLC45A2 (melanosome membrane transporter)
  • OA1: Abnormality of GPR143 (G protein-coupled receptor 143) → enlargement of melanosomes (macromelanosomes)

In OCA (autosomal recessive), if both parents are carriers, the probability of the child developing the condition is 25% (1 in 4). In OA1 (X-linked recessive), 50% of male children born to a carrier mother will develop the condition, while female children generally remain carriers.

Clinically suspected based on the combination of albinotic fundus, nystagmus, photophobia, and increased iris transillumination.

OCT (Optical Coherence Tomography): Absence of foveal depression is useful for confirming foveal hypoplasia. Foveal hypoplasia is characteristic of this condition and serves as a diagnostic basis.

Fluorescein Angiography: Can confirm the absence or reduction of the foveal avascular zone.

VEP (Visual Evoked Potentials): Useful for detecting chiasmal misrouting (excessive crossing of nerve fibers at the optic chiasm). Normally, nerve fibers from the temporal retina project to the ipsilateral lateral geniculate body, but in albinism, they cross excessively. VEP shows characteristic asymmetry with a large response over the occipital region contralateral to the stimulated eye. This also causes stereopsis impairment.

ERG: Normal in OA1, useful for differential diagnosis.

Genetic testing: Search for causative gene mutations in OCA1–4 (TYR, OCA2, TYRP1, SLC45A2) and OA1 (GPR143).

Carrier diagnosis (OA1): Examine the mother’s fundus to confirm mosaic depigmentation and pigment spots.

Waardenburg syndrome: An autosomal dominant genetic disorder (PAX3/MITF gene abnormalities) characterized by iris heterochromia (different colored eyes), systemic pigment abnormalities, and hearing loss. The fundus shows mild depigmentation, but unlike albinism, macular hypoplasia is absent.

Currently, there is no established curative treatment for oculocutaneous albinism or ocular albinism. The goal of management is to maximize residual visual function and improve quality of life.

Appropriate correction of myopia and astigmatism is the most important therapeutic intervention. In childhood, early and proper prescription of glasses is necessary to prevent amblyopia.

If there is a difference in visual acuity between the eyes, amblyopia treatment (occlusion therapy of the healthy eye) is performed.

Light-filtering glasses (filter lenses that cut specific wavelengths) and sunglasses are useful for managing photophobia. They are recommended for use both indoors and outdoors.

Surgical intervention (extraocular muscle surgery) is generally not standard. If there is an abnormal head posture (compensatory head posture), the use of prism glasses or extraocular muscle surgery to alleviate nystagmus may be considered.

Actively use visual aids such as magnifiers, video magnifiers, and tablet devices. Optimizing the lighting environment (using indirect lighting, reducing glare) is also important. For school-age children, adapting the educational environment (seating arrangement, enlarged materials, font size adjustment) directly supports learning.

In OCA, the lack of melanin in the skin significantly reduces protection against ultraviolet radiation. Daily practices such as using high-SPF sunscreen, wearing hats and long sleeves, and staying in the shade are necessary. Attention should be paid to the increased risk of skin cancer.

Providing genetic information to families according to the inheritance pattern (AR, XLR) is important.

7. Pathophysiology and detailed pathogenesis

Section titled “7. Pathophysiology and detailed pathogenesis”

Melanin synthesis pathway and abnormalities in each type

Section titled “Melanin synthesis pathway and abnormalities in each type”

Melanin is produced in vesicles called melanosomes within melanocytes. Tyrosinase (TYR) acts as the rate-limiting enzyme, converting tyrosine → DOPA → dopaquinone → eumelanin (black-brown) or pheomelanin (yellow-red).

In OCA1a, tyrosinase is completely nonfunctional, so no melanin is produced (complete albinism). In OCA1b, tyrosinase activity is only reduced, resulting in trace melanin production (incomplete albinism). The OCA2 protein in OCA2 is involved in regulating melanosomal pH, and its loss of function indirectly reduces tyrosinase activity. SLC45A2 in OCA4 is a transporter on the melanosomal membrane, necessary for supplying cofactors for pigment synthesis.

Melanin deficiency in the retinal pigment epithelium (RPE) increases light scattering and reduces visual quality. Normally, black melanin in the RPE absorbs light and reduces background noise, but this function is impaired in albinism.

During embryonic development, foveal differentiation requires melanin in the RPE and signaling molecules produced by the RPE. Pigment deficiency leads to insufficient signaling, preventing complete formation of the foveal pit (foveal hypoplasia). Absence of the foveal pit on OCT is a result of this.

Normally, about 40% of optic nerve fibers from the temporal retina do not cross at the chiasm and project to the ipsilateral lateral geniculate nucleus. In albinism, this proportion decreases, causing excessive crossing. As a result, corresponding visual field areas from both eyes do not project to the same hemisphere’s lateral geniculate nucleus, impairing binocular correlation essential for stereopsis. VEP asymmetry reflects this neuroanatomical abnormality.

Loss of function of GPR143 (G protein-coupled receptor) leads to enlargement of melanosomes (macromelanosomes). Giant melanosomes can be detected by electron microscopy or fundus examination, providing histological and imaging clues for OA1 diagnosis.

Oculocutaneous albinism and ocular albinism are non-progressive diseases. The severity of visual impairment varies by type; OCA1a is the most severe (often corrected visual acuity of 0.1 or less), while OCA2 and OA1 may be somewhat better.

Nystagmus tends to become less noticeable with growth. Visual acuity itself rarely improves significantly, but appropriate low vision care can maximize the use of residual visual function.

In syndromic albinism (Chédiak-Higashi syndrome, Hermansky-Pudlak syndrome), systemic complications such as immunodeficiency and bleeding tendency affect the prognosis, so collaboration with pediatrics and internal medicine is important.

Q How much can the vision of a child with albinism improve?
A

Corrected visual acuity ranges from about 0.1 to 0.5 depending on the degree of foveal hypoplasia. There is no curative treatment, but appropriate refractive correction and low vision care can maximize residual vision. Nystagmus tends to decrease with growth, which may improve apparent visual function.

Q How are ocular albinism (OA) and oculocutaneous albinism (OCA) differentiated?
A

OCA involves extensive hypopigmentation of the skin, hair, and eyes, whereas OA is limited to the eyes. OA is X-linked recessive, and mosaic depigmented patches in the peripheral fundus of carrier mothers can be a diagnostic clue. Genetic testing confirming GPR143 mutation establishes the diagnosis.

Q What should be noted in daily life for albinism?
A

Regular use of tinted glasses (for photophobia), UV protection (sunscreen and hats), and optimization of indoor lighting are important. Low-vision aids such as magnifiers and magnifying reading devices are also useful. During school age, adjustments in the educational environment (seating arrangement, enlarged materials) are necessary for learning support. Daily UV protection is also important to reduce the risk of skin cancer.

  1. Thomas MG, Kumar A, Mohammad S, et al. Structural grading of foveal hypoplasia using spectral-domain optical coherence tomography: a predictor of visual acuity? Ophthalmology. 2011;118(8):1653-1660. PMID: 21529956
  2. Seo JH, Yu YS, Kim JH, Choung HK, Heo JW, Kim SJ. Correlation of visual acuity with foveal hypoplasia grading by optical coherence tomography in albinism. Ophthalmology. 2007;114(8):1547-1551. PMID: 17337060
  3. Dorey SE, Neveu MM, Burton LC, Sloper JJ, Holder GE. The clinical features of albinism and their correlation with visual evoked potentials. Br J Ophthalmol. 2003;87(6):767-772. PMID: 12770978
  4. Fernández A, Hayashi M, Garrido G, et al. Genetics of non-syndromic and syndromic oculocutaneous albinism in human and mouse. Pigment Cell Melanoma Res. 2021;34(4):786-799. PMID: 33960688
  5. Ma EZ, Zhou AE, Hoegler KM, Khachemoune A. Oculocutaneous albinism: epidemiology, genetics, skin manifestation, and psychosocial issues. Arch Dermatol Res. 2023;315(2):107-116. PMID: 35217926

Copy the article text and paste it into your preferred AI assistant.